Assess Med Options When Standard Heart Failure Therapy Isn't Enough

August 2018

We're getting questions about managing patients admitted with heart failure exacerbations despite standard therapy.

First verify adherence to target doses of meds that decrease mortality in heart failure with reduced ejection fraction (HFrEF)...an ACEI or ARB, an "evidence-based" beta-blocker (carvedilol, etc), plus an aldosterone antagonist. About half of patients may not be adherent.

Weigh the options below if treatment adjustments are needed.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote